(Press-News.org) Adalimumab (an anti-tumor necrosis factor [TNF] antibody) is effective in maintaining remission in certain pediatric patients with Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
Steroids are commonly used in Crohn's disease, but can stunt growth and delay puberty. Incidence of this disease, which causes intestinal inflammation, is on the rise in children.
This study is the largest double-blind study of an anti-TNF agent in children with Crohn's disease. It found that more than 80 percent of children with moderate to severe Crohn's disease responded to adalimumab within a month (response was defined as a decrease in Pediatric Crohn's Disease Activity Index ≥ 15 points from baseline). By six months, approximately 34 percent of patients were in clinical remission, and after a year, 28.4 percent were in remission.
The promising results of treatment with adalimumab are extremely encouraging, especially in this clinically challenging population resistant to conventional therapy. The goal of treatment is not only to induce and maintain clinical remission, but also to restore and preserve normal growth and pubertal development in these children.
Researchers studied 192 patients, ages 6 to 17 years, across 45 sites in Canada, Europe and the U.S. between April 2007 and May 2010. Depending on their body weight, patients were assigned to either a high-dose group, which received 40 mg of adalimumab every other week or 20 mg of adalimumab every other week. Patients assigned to a low-dose group either received 20 mg of adalimumab every other week or 10 mg of adalimumab every other week, again depending on their body weight. More children that received high than low dose were in remission at week 26, but the difference between dose groups was not statistically significant.
###
About the AGA Institute
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org.
About Gastroenterology
Gastroenterology, the official journal of the AGA Institute, is the most prominent scientific journal in the specialty and is in the top 1 percent of indexed medical journals internationally. The journal publishes clinical and basic science studies of all aspects of the digestive system, including the liver and pancreas, as well as nutrition. The journal is abstracted and indexed in Biological Abstracts, Current Awareness in Biological Sciences, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Nutrition Abstracts and Science Citation Index. For more information, visit www.gastrojournal.org.
Like AGA on Facebook.
Join AGA on LinkedIn.
Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.
Adalimumab is a promising therapy for children with Crohn's disease
2012-08-06
ELSE PRESS RELEASES FROM THIS DATE:
'Green biased' yellow fever swept through Irish Immigrants in 19th century US
2012-08-06
New research by University of Warwick historian Dr Tim Lockley has found why yellow fever had a green bias in 19th century fever outbreaks in the southern states of the US. Almost half of the 650 people killed by yellow fever in Savannah Georgia in 1854 were Irish immigrants.
Dr Tim Lockley's study is based on four sources: the burial records of Laurel Grove cemetery; the records of the city's Catholic cemetery; the minutes of Savannah's Board of Health; and published lists of the dead in the Savannah Morning News. These sources yielded the names of 650 people who died ...
Infants of overweight mothers grow more slowly
2012-08-06
Pregnant women who are overweight or obese can encounter a host of health complications. The added weight also appears to affect how their children grow and develop, at least initially.
In a new study published in the Journal of Pediatrics, a team led by a University of Iowa researcher compared the weight and height of babies born to overweight and obese mothers with those born to normal-weight mothers.
Contrary to expectations, babies of overweight/obese mothers gained less weight and grew less in length than babies of normal-weight women from just after birth to ...
Brain's stem cells 'eavesdrop' to find out when to act
2012-08-06
Working with mice, Johns Hopkins researchers say they have figured out how stem cells found in a part of the brain responsible for learning, memory and mood regulation decide to remain dormant or create new brain cells. Apparently, the stem cells "listen in" on the chemical communication among nearby neurons to get an idea about what is stressing the system and when they need to act.
The researchers say understanding this process of chemical signaling may shed light on how the brain reacts to its environment and how current antidepressants work, because in animals these ...
Creatine aids women in outmuscling major depression
2012-08-06
(SALT LAKE CITY)—Women battling stubborn major depression may have a surprising new ally in their fight—the muscle-building dietary supplement creatine.
In a new proof-of-concept study, researchers from three South Korean universities and the University of Utah report that women with major depressive disorder (MDD) who augmented their daily antidepressant with 5 grams of creatine responded twice as fast and experienced remission of the illness at twice the rate of women who took the antidepressant alone. The study, published Aug. 3, 2012, in the American Journal of Psychiatry ...
Those who are covered, recover
2012-08-06
Insurance status is a better predictor of survival after a serious cardiac event than race, and may help explain racial disparities in health outcomes for cardiovascular disease. A new study by Derek Ng, from the Johns Hopkins Bloomberg School of Public Health in the US, and his team shows that race is not linked to an increased risk of death but being underinsured is a strong predictor of death among those admitted into hospital with a serious cardiac event. Their work¹ appears online in the Journal of General Internal Medicine², published by Springer.
African Americans ...
Moffitt Cancer Center researcher & colleagues test new drug for patients with neuroendocrine tumors
2012-08-06
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG. The Phase II, open-label, multicenter study in patients with advanced neuroendocrine tumors (NET) whose symptoms were no longer responsive to octreotide LAR therapy found that the drug was effective and well tolerated in controlling patient symptoms.
The study results are reported in a recent issue of Endocrine-Related Cancer, a publication of ...
Increased productivity, not less energy use, results from more efficient lighting
2012-08-06
ALBUQUERQUE, N.M. — Two researchers have reprised in the journal Energy Policy their groundbreaking finding that improvements in lighting — from candles to gas lamps to electric bulbs — historically have led to increased light consumption rather than lower overall energy use by society.
In an article in the journal Energy Policy, Sandia researcher Jeff Tsao and Harry Saunders of The Breakthrough Institute in Oakland, Calif., predicted in 2010 that the same phenomenon might apply to light-emitting diodes (LEDs), poised to take over from the Edison light bulb as the ...
White blood cells mediate insulin resistance
2012-08-06
Researchers at the University of California, San Diego School of Medicine say neutrophils, an abundant type of white blood cell typically tasked with attacking bacteria and other foreign invaders, also plays an unexpected role in mediating insulin resistance – the central characteristic of type 2 diabetes, which afflicts an estimated 26 million Americans.
The findings are published in the August 5, 2012 Advance Online Publication of Nature Medicine.
Neutrophils are the first immune cells to respond to tissue inflammation, and can promote chronic inflammation by summoning ...
New study finds link between cell division and growth rate
2012-08-06
CAMBRIDGE, Mass. -- It's a longstanding question in biology: How do cells know when to progress through the cell cycle?
In simple organisms such as yeast, cells divide once they reach a specific size. However, determining if this holds true for mammalian cells has been difficult, in part because there has been no good way to measure mammalian cell growth over time.
Now, a team of MIT and Harvard Medical School (HMS) researchers has precisely measured the growth rates of single cells, allowing them to answer that fundamental question. In the Aug. 5 online edition of ...
Sequencing of malaria genomes reveals challenges, opportunities in battle against parasite
2012-08-06
Genetic variability revealed in malaria genomes newly sequenced by two multi-national research teams points to new challenges in efforts to eradicate the parasite, but also offers a clearer and more detailed picture of its genetic composition, providing an initial roadmap in the development of pharmaceuticals and vaccines to combat malaria.
The research appears in two studies published in the latest issue of the journal Nature Genetics. They focus on Plasmodium vivax (P. vivax), a species of malaria that afflicts humans and the most prevalent human malaria parasite outside ...